| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2002 | EP0831902A4 Muscle trophic factor |
| 04/17/2002 | EP0805156B1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 04/17/2002 | EP0804186B1 Indole diterpene alkaloid compounds |
| 04/17/2002 | EP0799224B1 Quinoxalines and drugs prepared therefrom |
| 04/17/2002 | EP0799035B1 Emulsion suitable for administering a sphingolipid and use thereof |
| 04/17/2002 | EP0783514B1 Sterol compositions from pulping soap |
| 04/17/2002 | EP0749305B1 Process for making avermectin/zein compositions |
| 04/17/2002 | EP0744947B1 Modified-release metronidazole compositions and methods for making and using same |
| 04/17/2002 | EP0740550B1 Use of mometasone furoate for treating airway passage and lung diseases |
| 04/17/2002 | EP0706395B1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 04/17/2002 | EP0680325B1 Transdermal therapeutic system with galanthamine as active ingredient |
| 04/17/2002 | EP0676951B1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
| 04/17/2002 | EP0663830B1 Method of treating lung disease with uridine triphosphates |
| 04/17/2002 | EP0662827B1 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 04/17/2002 | EP0660708B1 Phospholipids |
| 04/17/2002 | EP0623146B1 Compositions and methods for inhibiting beta-protein function |
| 04/17/2002 | EP0607278B1 Method for enhancing gut absorption |
| 04/17/2002 | EP0607178B1 Methods for the isolation and fusion of cells |
| 04/17/2002 | EP0585371B1 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules |
| 04/17/2002 | CN1345375A Streptococcus pneumoniae antigens |
| 04/17/2002 | CN1345373A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 04/17/2002 | CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345327A 阿维菌素衍生物 Avermectin derivatives |
| 04/17/2002 | CN1345321A Optically pure camptothecin analogues |
| 04/17/2002 | CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 04/17/2002 | CN1345319A Triazole compounds with dopamine-D3-receptor affinity |
| 04/17/2002 | CN1345318A Triazole compounds with dopamine -D3-receptor affinity |
| 04/17/2002 | CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1345314A Amine derivatives as protease inhibitors |
| 04/17/2002 | CN1345313A Pesticidal enantiomer-pure 2,4-disubstituted oxazolines |
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345246A Compositions and method for prevention or treatment of cancer and bone loss associated with cancer |
| 04/17/2002 | CN1345242A Method for treatment of leukaemia |
| 04/17/2002 | CN1345241A In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/17/2002 | CN1345240A Improved cancer treatment with temozolomide |
| 04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
| 04/17/2002 | CN1345238A Method for treatment of neurological or neuropsychiatric disorders |
| 04/17/2002 | CN1345237A Method for prevention or reduction of cariovascular events associated with coronary intervention |
| 04/17/2002 | CN1345236A Swallowable tablets with high content of N-acetylcysteine |
| 04/17/2002 | CN1345235A Granulate with high content of L-carnitine or alkanoyl L-carnitine |
| 04/17/2002 | CN1345233A Pregelatinized starch in controlled release formulation |
| 04/17/2002 | CN1345231A Agglomerates by crystallisation |
| 04/17/2002 | CN1345229A Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 04/17/2002 | CN1345228A Dermatological topical composition |
| 04/17/2002 | CN1345213A Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 04/17/2002 | CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 04/17/2002 | CN1345188A Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 04/17/2002 | CN1344747A Antitumor carboxyalkyl achyranthis polysaccharide |
| 04/17/2002 | CN1344722A Amino polyoligoglucosan with 1-6 connection and glucoside and their synthesis and application |
| 04/17/2002 | CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect |
| 04/17/2002 | CN1344715A Thenoyl piperazine derivative with positive myodyamia effect |
| 04/17/2002 | CN1344709A Novel di-quaternary ammonium salt compound |
| 04/17/2002 | CN1344550A Beriberi treating Jiaoyuxiang ointment prepared with Chinese and Western medicine material |
| 04/17/2002 | CN1344544A Specific burn-treating Chinese medicine prepn. |
| 04/17/2002 | CN1344541A Water soluble Azithromycin salt and its eye drop |
| 04/17/2002 | CN1344540A Application of calcium L-threonate in treating cartilage related diseases |
| 04/17/2002 | CN1082999C Protease-containing cleaning compositions |
| 04/17/2002 | CN1082963C Isoxazolidine derivatives |
| 04/17/2002 | CN1082961C Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal and applications as medicine and pharmaceutical compositions thereof |
| 04/17/2002 | CN1082959C Substituted benzothienylpiperazines, their use as medicaments and processes for their preparation |
| 04/17/2002 | CN1082958C Alternate crystal form of tazofelone |
| 04/17/2002 | CN1082950C Quinoline derivatives containing diol as leukotriene antagonists |
| 04/17/2002 | CN1082948C 4-amino-1-piperidylbenzoylguanidine |
| 04/17/2002 | CN1082822C Cosmetic and skin-useful composition containing water from hot spring or mineral water and agent against acne and oldening |
| 04/17/2002 | CN1082820C Purified extract of harpagophytum procumbens and/or Harpagophytum zeyherii DENCE, process for its prodn. and its use |
| 04/17/2002 | CN1082819C United pharmaceutical system for abrogation of viral resistance to nucleoside analogues by double-stranded RNAS |
| 04/17/2002 | CN1082818C 1 alpha, 24-(OH)2-V D3-emulsion composition |
| 04/17/2002 | CN1082817C Corticosteroid-containing pharmaceutical compositions |
| 04/17/2002 | CN1082816C Use of penciclorim for treatment of post-therapeutic neuralgia |
| 04/17/2002 | CN1082815C 吲哚衍生物 Indole derivatives |
| 04/17/2002 | CN1082814C Nodulisporic acid derivatives |
| 04/17/2002 | CN1082813C Stabized solutions of platinum (II) antitumor agents |
| 04/17/2002 | CN1082812C Parenteral pharmaceutical compositions and containing ammoniumalkyl salts of 2-arylpropionic acids |
| 04/17/2002 | CN1082809C 肥皂组合物 Soap compositions |
| 04/17/2002 | CN1082806C Packaged antibacterial antiplaque oral composition |
| 04/17/2002 | CA2358802A1 Method of treating cartilage damage |
| 04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
| 04/16/2002 | US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof |
| 04/16/2002 | US6372919 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| 04/16/2002 | US6372917 Inhibit cellular sodium ion-dependent chloride ion/bicarbonate-exchange mechanism or sodium/bicarbonate symporter; treatment of all acute or chronic damage caused by ischemia or illnesses induced thereby |
| 04/16/2002 | US6372888 Useful for combating fungal diseases in agricultural, pharmaceutical or preservative applications |
| 04/16/2002 | US6372883 For therapy and prophylaxis of infections caused by hepatitis c, hepatitis g and human gb viruses |
| 04/16/2002 | US6372802 Aniline disulfide derivatives for treating allergic diseases |
| 04/16/2002 | US6372799 Antiallergens or cholinergic disorders |
| 04/16/2002 | US6372798 Treatment of hyperactivity |
| 04/16/2002 | US6372797 Treatment of menstrual function |
| 04/16/2002 | US6372796 Increasing hematopietic stem cells |
| 04/16/2002 | US6372794 Antiarthritic agents |
| 04/16/2002 | US6372793 Nervous system disorders, methylation demethylation for neuromodulator functions |
| 04/16/2002 | US6372792 Sedatives for insomnia |
| 04/16/2002 | US6372791 Applying carnitine to skin in mixtures with pyruvic acid |
| 04/16/2002 | US6372790 Metformin, fibrate such as fenofibrate and bezafibrate with excipients |
| 04/16/2002 | US6372788 Method for supplying bioavailable methionine to a cow |